227 related articles for article (PubMed ID: 18802116)
1. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists.
Roses RE; Xu S; Xu M; Koldovsky U; Koski G; Czerniecki BJ
J Immunol; 2008 Oct; 181(7):5120-7. PubMed ID: 18802116
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
4. High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production.
Xu S; Koldovsky U; Xu M; Wang D; Fitzpatrick E; Son G; Koski G; Czerniecki BJ
Surgery; 2006 Aug; 140(2):170-8. PubMed ID: 16904966
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
7. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
8. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
9. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
[TBL] [Abstract][Full Text] [Related]
10. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.
Duraisingham SS; Hornig J; Gotch F; Patterson S
J Immunol; 2009 Aug; 183(4):2242-51. PubMed ID: 19625644
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
12. Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generation.
Wang Q; Franks HA; Porte J; El Refaee M; Shah S; Crooks J; Patel PM; Jackson AM
Immunology; 2011 Sep; 134(1):60-72. PubMed ID: 21718315
[TBL] [Abstract][Full Text] [Related]
13. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells.
Doxsee CL; Riter TR; Reiter MJ; Gibson SJ; Vasilakos JP; Kedl RM
J Immunol; 2003 Aug; 171(3):1156-63. PubMed ID: 12874201
[TBL] [Abstract][Full Text] [Related]
14. TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2.
Schwarz H; Posselt G; Wurm P; Ulbing M; Duschl A; Horejs-Hoeck J
Immunobiology; 2013 Apr; 218(4):533-42. PubMed ID: 22795647
[TBL] [Abstract][Full Text] [Related]
15. Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-γ production by CD4+ T cells.
Valencia J; Martínez VG; Hidalgo L; Hernández-López C; Canseco NM; Vicente A; Varas A; Sacedón R
Immunol Lett; 2014 Nov; 162(1 Pt A):188-99. PubMed ID: 25196330
[TBL] [Abstract][Full Text] [Related]
16. Double stranded RNA- relative to other TLR ligand-activated dendritic cells induce extremely polarized human Th1 responses.
Benwell RK; Hruska JE; Fritsche KL; Lee DR
Cell Immunol; 2010; 264(2):119-26. PubMed ID: 20547386
[TBL] [Abstract][Full Text] [Related]
17. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors.
Lehner M; Morhart P; Stilper A; Petermann D; Weller P; Stachel D; Holter W
J Immunother; 2007 Apr; 30(3):312-22. PubMed ID: 17414322
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
[TBL] [Abstract][Full Text] [Related]
19. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Boullart AC; Aarntzen EH; Verdijk P; Jacobs JF; Schuurhuis DH; Benitez-Ribas D; Schreibelt G; van de Rakt MW; Scharenborg NM; de Boer A; Kramer M; Figdor CG; Punt CJ; Adema GJ; de Vries IJ
Cancer Immunol Immunother; 2008 Nov; 57(11):1589-97. PubMed ID: 18322684
[TBL] [Abstract][Full Text] [Related]
20. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
Chen XZ; Mao XH; Zhu KJ; Jin N; Ye J; Cen JP; Zhou Q; Cheng H
Arch Dermatol Res; 2010 Jan; 302(1):57-65. PubMed ID: 19578865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
